Anticholinergic burden
1 paper1 finding
Associations
1Mortality
upin humans1HR 1.4
1 study
Mortality
upin humans1HR 1.4
Anticholinergic burden raises the risk of mortality in humans (HR 1.40, 95% CI 1.22-1.61).
“Overall, pooled analysis showed a 40% higher mortality risk in patients with high anticholinergic burden (HR = 1.40; 95% CI 1.22-1.61; p < 0.001).”
Reviewafter hip fracture
British journal of clinical pharmacology14 Aug 2026
Latest
14 in 12 monthsJournal of Medical and Biosciences Research
Association between cumulative anticholinergic burden and dementia risk in older adults: An integrative literature review
Systematic reviewDementia
Geriatrics & Gerontology International
Japanese Anticholinergic Risk Scale and Domain-Specific Functional Outcomes in Older Poststroke Patients
Cohort study of 747 peopleBiomarkers
European Journal of Clinical Pharmacology
Response to "Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study"
Study in peoplePopulations
British Journal of Clinical Pharmacology
HIV and anticholinergic burden: Towards a pragmatic stewardship algorithm
ReviewInterventions
Internal and Emergency Medicine
Clinically recognized sepsis in older adults admitted to medical wards: patient characteristics and hospital outcomes from the REPOSI register
Cohort study of 8,880 peopleSepsis
British Journal of Clinical Pharmacology
Higher anticholinergic burden is associated with increased medium- and long-term mortality following hip fracture: A systematic review and meta-analysis
Meta-analysis of observational studiesHip fracture
JMA Journal
Associations between Anticholinergic Burden and Skeletal Muscle Indices and Physical Function in Older Adults: A Scoping Review
Systematic review of studies in peopleMuscle
European Journal of Clinical Pharmacology
Cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study
Cross-sectional study of 872 peoplePopulations
Age and Ageing
Polypharmacy, anticholinergic burden and inflammation in relation to accelerated biological ageing
Cross-sectional study of 10,556 peoplePhenoAge